Los Angeles Capital Management
HCAT icon

Los Angeles Capital Management’s Health Catalyst HCAT Stock Holding History

Los Angeles Capital Management’s Portfolio HCAT Stock Details HCAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-106,460
Closed -$482K – 1388
2025
Q1 		$482K Sell
106,460
-14,890
-12% -$78.8K ﹤0.01% 754
2024
Q4 		$858K Sell
121,350
-40,378
-25% -$322K ﹤0.01% 667
2024
Q3 		$1.32M Sell
161,728
-51,965
-24% -$376K 0.01% 558
2024
Q2 		$1.37M Buy
213,693
+156,908
+276% +$1.01M ﹤0.01% 551
2024
Q1 		$428K Buy
56,785
+45,115
+387% +$412K ﹤0.01% 921
2023
Q4 		$108K Buy
+11,670
New +$95.4K ﹤0.01% 1113

Other funds holding HCAT

FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WCA
Whetstone Capital Advisors Shawnee Mission, Kansas $380M AUM 20.01% 1-Year Est. Return
Impax Asset Management Group
Impax Asset Management Group London, United Kingdom $15.4B AUM 26.43% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
PCM
Portolan Capital Management Boston, Massachusetts $2.67B AUM 169.09% 1-Year Est. Return
NI
Nepsis Inc Minneapolis, Minnesota $295M AUM 35.44% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Los Angeles Capital Management's HCAT Position: Q2 2025 in Review

Los Angeles Capital Management sold out of Health Catalyst (HCAT) in Q2 2025, closing a stake of 106,460 shares — an estimated $482K sold.

Los Angeles Capital Management first reported a position in HCAT in Q4 2023 and held it in 6 quarters. The position peaked at $1.37M in Q2 2024. 145 funds tracked by Wall St. Rank hold HCAT as of Q2 2025.

  • Los Angeles Capital Management reported no remaining Health Catalyst position as of Q2 2025 after selling out during the quarter.
  • Los Angeles Capital Management sold 106,460 Health Catalyst shares in Q2 2025, an estimated $482K.
  • Los Angeles Capital Management first reported a position in Health Catalyst in Q4 2023 and held it in 6 quarters.
  • Los Angeles Capital Management's Health Catalyst position peaked at $1.37M in Q2 2024.
  • 145 funds tracked by Wall St. Rank held Health Catalyst as of Q2 2025.

Based on Los Angeles Capital Management's 13F filing for Q2 2025, filed 7 Aug 2025.